Connection
Marc Goalstone to Hypoglycemic Agents
This is a "connection" page, showing publications Marc Goalstone has written about Hypoglycemic Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.240 |
|
|
|
-
Solomon CS, Leitner JW, Goalstone ML. Dominant negative alpha-subunit of farnesyl- and geranylgeranyl-transferase I inhibits insulin-induced differentiation of 3T3-L1 pre-adipocytes. Int J Obes Relat Metab Disord. 2003 Jan; 27(1):40-7.
Score: 0.101
-
Goalstone ML, Draznin B. Effect of insulin on farnesyltransferase gene transcription and mRNA stability. Biochem Biophys Res Commun. 1999 Jan 08; 254(1):243-7.
Score: 0.077
-
Goalstone ML. ERK5: a novel IKKa-kinase in rat hippocampal neurons. Can J Neurol Sci. 2011 Jul; 38(4):639-48.
Score: 0.046
-
Stith BJ, Goalstone ML, Espinoza R, Mossel C, Roberts D, Wiernsperger N. The antidiabetic drug metformin elevates receptor tyrosine kinase activity and inositol 1,4,5-trisphosphate mass in Xenopus oocytes. Endocrinology. 1996 Jul; 137(7):2990-9.
Score: 0.016